 GUILFORD, Conn.--BUSINESS WIRE--Mar. 28, 2022--Quantum-Si Incorporated Nasdaq: QSI Quantum-Si, QSI or the Company, a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the B. Riley Disruptive Biotech Enabling Technologies Virtual Mini Conference. Quantum-Sis management is scheduled to present virtually on Thursday, April 7, 2022 at 10:20 am ET. To listen to the live event, please contact your B. Riley Securitie 